The Centers for Disease Control and Prevention (CDC) in the United States now reports over 300,000 new cases of Lyme disease each year.
Furthermore, due to challenges in identification and diagnosis, the precise number of individuals affected remains unknown, solidifying Lyme disease as the fastest-growing infectious disease in the U.S.
The tick-borne bacterium, Borrelia burgdorferi, creates a protective biofilm to evade the immune system and can remain dormant for extended periods. Antibiotic treatments alone frequently fail to offer adequate symptomatic relief.
Hyperbaric oxygen therapy (HBOT) has been demonstrated to elevate tissue oxygenation levels, which can be lethal to bacteria such as Borrelia burgdorferi. Additionally, HBOT increases white blood cell activity and enhances antimicrobial responses. The increased oxygen levels throughout the body significantly enhance the bactericidal action of white blood cells, thereby improving the efficiency of microbial eradication.
Clinical data and case reports have substantiated the enduring advantages of HBOT for Lyme disease, including the following:
The research article underscores the benefits of hyperbaric oxygen therapy for individuals with Lyme disease.
If you have questions about a particular symptom or condition related to Lyme disease, feel free to ask!
In an exploratory trial conducted at Texas A&M University, 91 patients with Lyme disease were evaluated for the effects of HBOT. All patients had previously failed to respond to intravenous antibiotics, and 67% continued antibiotic treatment during the trial. Patients, spanning from children to adults, received anywhere from 10 to 133 HBOT sessions (60 minutes, twice daily, five days a week), with 75% completing the treatment. Approximately 85% of patients experienced significant improvement, with symptoms decreasing or being eliminated. Most patients continued to show major improvements even after the conclusion of HBOT, and follow-up ranging from 6 weeks to 6 years indicated sustained benefits in approximately 70% of patients.
The information provided on this website is for educational purposes only and should not be viewed as a substitute for the diagnosis, treatment, or advice of a qualified licensed professional. This website offers general information and does not represent the practice of medicine. We do not take responsibility for how this information is utilized. Additionally, please note that the contents of this website are regularly updated for various reasons. Any statements or implied treatments have not been evaluated or approved by the FDA. It is crucial not to alter, discontinue, or change any medication or treatment without consulting your doctor first. Always seek your doctor’s advice before initiating any new treatment program.
Learn about purchase and rental programs.
Copyright © 2024 Hyperbaric Hub LLC All Rights Reserved
